Article
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.
Neoplasia (New York, N.Y.) - 1 Apr 2009
Rodriguez Rene, Rubio Ruth, Masip Manuel, Catalina Purificación, Nieto Ana, de la Cueva Teresa, Arriero Mar, San Martin Nuria, de la Cueva Ernesto, Balomenos Dimitrios, Menendez Pablo, García-Castro Javier
Abstract excerpt
There is growing evidence about the role of mesenchymal stem cells (MSCs) as cancer stem cells in many sarcomas. Nevertheless, little is still known about the cellular and molecular mechanisms underlying MSCs transformation. We aimed at investigating the role of p53 and p21, two important regulators of the cell cycle progression and apoptosis normally involved in protection against tumorigenesis. Mesenchymal stem...
Topics
- Animals
- Blotting, Western
- Cell Transformation, Neoplastic
- Cellular Senescence
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinase Inhibitor p21
- Flow Cytometry
- Mesenchymal Stem Cells
- Mice
